| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| moroctocog alfa | asialoglycoprotein receptor 2 | biotech | NA | drugbank | Operative Surgical Procedures[MeSHID:D013514] Hemorrhage[MeSHID:D006470] Hemophilia A[MeSHID:D006467] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | binder |
| moroctocog alfa | calreticulin | biotech | NA | drugbank | Operative Surgical Procedures[MeSHID:D013514] Hemorrhage[MeSHID:D006470] Hemophilia A[MeSHID:D006467] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | chaperone |
| moroctocog alfa | calnexin | biotech | NA | drugbank | Operative Surgical Procedures[MeSHID:D013514] Hemorrhage[MeSHID:D006470] Hemophilia A[MeSHID:D006467] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | chaperone |
| moroctocog alfa | coagulation factor x | biotech | NA | drugbank | Operative Surgical Procedures[MeSHID:D013514] Hemorrhage[MeSHID:D006470] Hemophilia A[MeSHID:D006467] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | activator |
| moroctocog alfa | coagulation factor ix | biotech | NA | drugbank | Operative Surgical Procedures[MeSHID:D013514] Hemorrhage[MeSHID:D006470] Hemophilia A[MeSHID:D006467] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | cofactor |
| moroctocog alfa | 78 kda glucose-regulated protein | biotech | NA | drugbank | Operative Surgical Procedures[MeSHID:D013514] Hemorrhage[MeSHID:D006470] Hemophilia A[MeSHID:D006467] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | chaperone |
| moroctocog alfa | protein ergic-53 | biotech | NA | drugbank | Operative Surgical Procedures[MeSHID:D013514] Hemorrhage[MeSHID:D006470] Hemophilia A[MeSHID:D006467] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | chaperone |
| moroctocog alfa | prolow-density lipoprotein receptor-related protein 1 | biotech | NA | drugbank | Operative Surgical Procedures[MeSHID:D013514] Hemorrhage[MeSHID:D006470] Hemophilia A[MeSHID:D006467] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | modulator |
| moroctocog alfa | multiple coagulation factor deficiency protein 2 | biotech | NA | drugbank | Operative Surgical Procedures[MeSHID:D013514] Hemorrhage[MeSHID:D006470] Hemophilia A[MeSHID:D006467] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | modulator |
| moroctocog alfa | phytanoyl-coa dioxygenase, peroxisomal | biotech | NA | drugbank | Operative Surgical Procedures[MeSHID:D013514] Hemorrhage[MeSHID:D006470] Hemophilia A[MeSHID:D006467] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| moroctocog alfa | von willebrand factor | biotech | NA | drugbank | Operative Surgical Procedures[MeSHID:D013514] Hemorrhage[MeSHID:D006470] Hemophilia A[MeSHID:D006467] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | binder |
| click here to return to the previous page | ||||||||